Developing a new detector system for ultra-rapid radiation therapy
Official title: TOPIC 461: A NOVEL SCINTILLATION DETECTOR SYSTEM FOR FLASH RADIATION THERAPY
Funded at Standard Imaging, INC. · NIH-11210772 · Data updated 2026-11-12
This study is working on a new type of detector to help doctors measure a fast radiation treatment called FLASH therapy, which aims to treat tumors while protecting healthy tissue, making radiation therapy safer and more effective for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Standard Imaging, INC. NIH-funded |
| Lab location | 1 site (Middleton, United States) |
| Project start | September 15, 2024 |
| Project end | September 14, 2025 |
| Funding year | 2024 |
| Award (this year) | $397,626 |
| NIH project number | 75N91024C00062-0-9999-1 |
| Project ID | NIH-11210772 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients undergoing radiation therapy for cancer who may benefit from advanced treatment methods that minimize damage to healthy tissues.
✕Less likely to help
Patients who are not receiving radiation therapy or those with conditions that do not involve tumor treatment may not benefit from this research.
What this research studies
This research focuses on creating a novel scintillator detector system designed to measure ultra-rapid FLASH radiation therapy, which delivers radiation doses in sub-second intervals. By improving the measurement of dose parameters, this project aims to enhance the understanding of how FLASH therapy can minimize damage to normal tissues while effectively treating tumors. The approach involves developing specialized plastic scintillator detectors that can provide real-time, precise dose measurements necessary for the clinical application of FLASH therapy. This advancement could lead to safer and more effective radiation treatment options for patients.
Why it matters
Potential benefit: If successful, this research could lead to improved radiation therapy techniques that reduce side effects for patients while maintaining effective tumor control.
How similar studies have gone: Previous research has shown promise in using advanced detection technologies for radiation therapy, indicating potential success for this novel approach.
Where this research is happening
-
Standard Imaging, INC.
Middleton, United States Active
Researchers
- Principal investigator: Holmes, Shannon M — Standard Imaging, INC.
- Study coordinator: Holmes, Shannon M
Related research
Other NIH-funded projects on the same topics.
-
Protecting small blood vessels from radiation by boosting mitochondrial health
It aims to prevent radiation-related damage to tiny blood vessels and reduce later thinking and memory problems in people who get radiation therapy by protecting cell mitochondria.
-
Proton SBRT for refractory ventricular tachycardia with real-time 3D/4D imaging
A patient-facing study exploring a proton-based, noninvasive radiation therapy to treat stubborn VT using advanced 3D and 4D imaging to target the heart safely.
-
Embedding symptom support in radiation therapy for prostate cancer
A multi-site study tests whether delivering mindfulness-based symptom support right inside radiation therapy is feasible and acceptable for men with prostate cancer.
-
Targeting SREBP2 to boost radiation therapy in HPV-negative head and neck cancer
This grant aims to see if blocking SREBP2 can make radiation therapy work better for people with HPV-negative Head and Neck Squamous Cell Carcinoma.
-
Genetic and Immune Factors in Squaring the Room: Sacituzumab plus Radiation for Bladder Cancer
A study aims to understand why combining sacituzumab with radiation helps some bladder cancer patients more than others, with the goal of making bladder-sparing therapy more effective.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.